Polypharmacy and potential drug–drug interactions with novel androgen receptor signaling inhibitors (ARSIs) in patients (pts) with high-risk non-metastatic castration-resistant prostate cancer (nmCRPC) in a real-world setting
| dc.contributor.author | D'SOUZA, EDWIN A. | |
| dc.contributor.author | VILLA, PAULO R. | |
| dc.contributor.author | CHIANN, CHANG | |
| dc.contributor.author | NAKANDAKARE, GUILHERME K. | |
| dc.contributor.author | COSTA, RAFAEL | |
| dc.contributor.author | MUNIZ, DAVID Q. B. | |
| dc.contributor.author | FREITAS, GUILHERME F. de | |
| dc.contributor.author | HORITA, VIVIAN N. | |
| dc.contributor.author | MARTINS, JOAO C. R. | |
| dc.contributor.author | RIBEIRO-FILHO, LEOPOLDO A. | |
| dc.contributor.author | SUARTZ, CAIO | |
| dc.contributor.author | CALVO, WILSON | |
| dc.contributor.author | ARAUJO, ELAINE B. de | |
| dc.contributor.author | NAHAS, WILLIAM C. | |
| dc.contributor.author | MOTA, JOSE M. | |
| dc.coverage | Internacional | |
| dc.date.accessioned | 2026-10-06T17:28:14Z | |
| dc.date.available | 2026-10-06T17:28:14Z | |
| dc.date.issued | 2026 | |
| dc.format.extent | 1 | |
| dc.identifier.doi | 10.1200/JCO.2026.44.7_suppl.346 | |
| dc.identifier.fasciculo | 7 | |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.orcid | https://orcid.org/0000-0002-4316-8335 | |
| dc.identifier.orcid | https://orcid.org/0000-0003-0456-5589 | |
| dc.identifier.percentilfi | 98.0 | |
| dc.identifier.percentilfiCiteScore | 90.5 | |
| dc.identifier.suplemento | suppl. | |
| dc.identifier.uri | https://repositorio.ipen.br/handle/123456789/50214 | |
| dc.identifier.vol | 44 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Journal of Clinical Oncology | |
| dc.rights | openAccess | |
| dc.source | American Society of Clinical Oncology Genitourinary Cancers Symposium, 26-28 de fevereiro, 2026, San Francisco, USA | |
| dc.title | Polypharmacy and potential drug–drug interactions with novel androgen receptor signaling inhibitors (ARSIs) in patients (pts) with high-risk non-metastatic castration-resistant prostate cancer (nmCRPC) in a real-world setting | |
| dc.type | Resumos em periódicos | |
| dspace.entity.type | Publication | |
| ipen.autor | WILSON APARECIDO PAREJO CALVO | |
| ipen.autor | ELAINE BORTOLETI DE ARAUJO | |
| ipen.codigoautor | 603 | |
| ipen.codigoautor | 664 | |
| ipen.contributor.ipenauthor | WILSON APARECIDO PAREJO CALVO | |
| ipen.contributor.ipenauthor | ELAINE BORTOLETI DE ARAUJO | |
| ipen.identifier.fi | 44.7 | |
| ipen.identifier.fiCiteScore | 14.2 | |
| ipen.identifier.ipendoc | 32299 | |
| ipen.identifier.iwos | WoS | |
| relation.isAuthorOfPublication | 39f410f2-b7d6-46e9-95ed-3bc77a28004f | |
| relation.isAuthorOfPublication | ca74886d-6974-47a8-9308-c4cc39bb6e35 | |
| relation.isAuthorOfPublication.latestForDiscovery | 39f410f2-b7d6-46e9-95ed-3bc77a28004f |